相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
Yang Shen et al.
EBIOMEDICINE (2015)
GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid
Ji Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Triple A therapy: The molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide
Jessica N. Nichol et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia
Yirui Chen et al.
BLOOD (2014)
Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells
Chengwu Zeng et al.
BMC CANCER (2014)
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy
Steven E. Coutre et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
RIG-I Modulates Src-Mediated AKT Activation to Restrain Leukemic Stemness
Xian-Yang Li et al.
MOLECULAR CELL (2014)
Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure
Julien Ablain et al.
NATURE MEDICINE (2014)
Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
Hong-Hu Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia
X-W Yang et al.
ONCOGENE (2014)
Rapid Reduction in Breast Cancer Mortality With Inorganic Arsenic in Drinking Water
Allan H. Smith et al.
EBIOMEDICINE (2014)
OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia
Dahae Won et al.
BLOOD (2013)
The Histone Demethylase PHF8 Governs Retinoic Acid Response in Acute Promyelocytic Leukemia
Maria Francisca Arteaga et al.
CANCER CELL (2013)
Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
Hong-Hu Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Arkadia, a Novel SUMO-Targeted Ubiquitin Ligase Involved in PML Degradation
Yigit Erker et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia
A. Pelosi et al.
ONCOGENE (2013)
8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation
Bo Jiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells
Elena A. Federzoni et al.
BLOOD (2012)
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Harry J. Iland et al.
BLOOD (2012)
The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA
Andrea Rabellino et al.
CANCER RESEARCH (2012)
Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond
Sai-Juan Chen et al.
IUBMB LIFE (2012)
From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia
Sai-Juan Chen et al.
BLOOD (2011)
Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment
Emi Goto et al.
BLOOD (2011)
Genome-wide functions of PML-RARα in acute promyelocytic leukaemia
S. Saeed et al.
BRITISH JOURNAL OF CANCER (2011)
Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
Ardeshir Ghavamzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation
Lin-Jia Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
Yukiya Yamamoto et al.
BLOOD (2010)
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
Bayard L. Powell et al.
BLOOD (2010)
PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
Kankan Wang et al.
CANCER CELL (2010)
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Joost H. A. Martens et al.
CANCER CELL (2010)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
PML-RARα and Dnmt3a1 Cooperate in vivo to Promote Acute Promyelocytic Leukemia
Deepa Subramanyam et al.
CANCER RESEARCH (2010)
Single Cycle of Arsenic Trioxide-Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia
Steven D. Gore et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
Hugues de The et al.
NATURE REVIEWS CANCER (2010)
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
Pau Montesinos et al.
BLOOD (2009)
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes
S. Careccia et al.
ONCOGENE (2009)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
UBE1L represses PML/RARα by targeting the PML domain for ISG15ylation
Surnit J. Shah et al.
MOLECULAR CANCER THERAPEUTICS (2008)
PML targeting eradicates quiescent leukaemia-initiating cells
Keisuke Ito et al.
NATURE (2008)
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Michael H. Tatham et al.
NATURE CELL BIOLOGY (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Rihab Nasr et al.
NATURE MEDICINE (2008)
RIG-I plays a critical role in negatively regulating granulocytic proliferation
Nan-Nan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia
Lan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells
Jordy Leung et al.
BLOOD (2007)
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
E Estey et al.
BLOOD (2006)
Retinoid/arsenic combination therapy of promyelocytic leukemia:: induction of telomerase-dependent cell death
I Tarkanyi et al.
LEUKEMIA (2005)
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: Updated outcomes of the phase II study and postremission therapies
K Shigeno et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Opinion -: How patients have benefited from mouse models of acute promyelocytic leukaemia
V Lallemand-Breitenbach et al.
NATURE REVIEWS CANCER (2005)
Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia
PZ Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Retinoic acid and arsenic for treating acute promyelocytic leukemia
GB Zhou et al.
PLOS MEDICINE (2005)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
A Insinga et al.
EMBO JOURNAL (2004)
Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation
Q Zhao et al.
LEUKEMIA (2004)
Retinoic acid receptor α and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death
F Pendino et al.
ONCOGENE (2003)
Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair
M Alcalay et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Retinoic acid resistance in acute promyelocytic leukemia
RE Gallagher
LEUKEMIA (2002)
PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
LM Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Variant-type PML-RARα fusion transcript in acute promyelocytic leukemia:: Use of a cryptic coding sequence from intron 2 of the RARα gene and identification of a new clinical subtype resistant to retinoic acid therapy
BW Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report
DP Lu et al.
BLOOD (2002)
UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia
S Kitareewan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Pathways of retinoic acid- or arsenic trioxide-induced PML/RARα catabolism, role of oncogene degradation in disease remission
J Zhu et al.
ONCOGENE (2001)
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
SL Soignet et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation
F Pendino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage
Y Shen et al.
LEUKEMIA (2001)
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
YK Jing et al.
BLOOD (2001)
Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers
RJ Lin et al.
MOLECULAR CELL (2000)
分享论文
